Expanding the Utility of Exome Sequencing in Preventive and Population Genetics
American Journal of Medical Genetics Part A · 2026
DOI: 10.1002/ajmg.a.70210 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2026. Verfasst von Charilaos Kostoulas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Genetics in Clinical Practice, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece. Hauptthemen laut MEDLINE: Exome Sequencing, Genetics, Population, Exome, Genetic Carrier Screening. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Carrier screening is a long‐standing genetic testing process offered to at‐risk couples, with or without a family history, who might have pregnancies affected by an autosomal recessive (AR) or X‐linked (XL) disorder. A total of 276 unrelated individuals, initially referred for rare disorder screening by clinicians, were enrolled in this study and tested by Exome sequencing (ES). Expanded carrier screening (ECS) was performed for 176 disorders that met the inclusion criteria of the ACMG and ACOG. Genes with single nucleotide variants (SNVs) identified with a carrier rate > 1% for AR disorders included HBB , CFTR , PMM2 , NPHS2 , GJB2 , ACADM , ALDOB , MEFV , MKS1 , NEB , PAH , ATM , CPT2 , CYP21A2 , AGXT , BBS1 , CAPN3 , COL4A4 , DHCR7 , GAA , IVD , LAMA2 , SLC22A5 , SLC26A4 , USH2A . For XL disorders, variants were detected in the RS1 gene. ECS offers a wealth of information about SNVs related to AR and XL disorders in specified populations. The information obtained from ECS provides multiple advantages: (a) it identifies the most prominent risks in health care in a given population and contributes to the prevention of genetic disorders, (b) it enriches available databases with pathogenic or likely pathogenic SNVs, and (c) it records novel targets for molecular clinical genetic testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Medical Genetics in Clinical Practice, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
- Assisting Nature, Centre of Reproduction and Genetics, Thessaloniki, Greece.
- Department of Neurology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
ORCID-Profile: Charilaos Kostoulas
Zitieren
APA
Kostoulas, C., Sesse, A., Bouba, I., Najdecki, R., Konitsiotis, S., Markoula, S., & Georgiou, I. (2026). Expanding the Utility of Exome Sequencing in Preventive and Population Genetics. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.70210
Vancouver
Kostoulas C, Sesse A, Bouba I, Najdecki R, Konitsiotis S, Markoula S, et al. Expanding the Utility of Exome Sequencing in Preventive and Population Genetics. American Journal of Medical Genetics Part A. 2026. doi:10.1002/ajmg.a.70210
BibTeX
@article{Kostoulas2026,
author = {Kostoulas, Charilaos and Sesse, Athanasia and Bouba, Ioanna and Najdecki, Robert and Konitsiotis, Spyridon and Markoula, Sofia and Georgiou, Ioannis},
title = {Expanding the Utility of Exome Sequencing in Preventive and Population Genetics},
journal = {American Journal of Medical Genetics Part A},
year = {2026},
doi = {10.1002/ajmg.a.70210}
}
EUVIMED